Currently, Gossamer Bio Inc [GOSS] is trading at $0.85, up 1.14%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The GOSS shares have gain 6.14% over the last week, with a monthly amount glided 22.07%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Gossamer Bio Inc [NASDAQ: GOSS] stock has seen the most recent analyst activity on June 25, 2024, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $9. On July 27, 2023, downgrade downgraded it’s rating to Neutral and revised its price target to $1.25 on the stock. Raymond James downgraded its rating to a Mkt Perform. Guggenheim initiated its recommendation with a Neutral. SMBC Nikko downgraded its rating to Neutral for this stock on December 07, 2022, but kept the price target unchanged to $3. In a note dated December 07, 2022, JP Morgan downgraded an Underweight rating on this stock.
This stock has fluctuated between a low of $0.50 and a high of $1.60 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $3.75 within the next 12 months. Gossamer Bio Inc [NASDAQ: GOSS] shares were valued at $0.85 at the most recent close of the market. An investor can expect a potential return of 341.18% based on the average GOSS price forecast.
Analyzing the GOSS fundamentals
Gross Profit Margin for this corporation currently stands at 0.97% with Operating Profit Margin at -0.56%, Pretax Profit Margin comes in at -0.61%, and Net Profit Margin reading is -0.64%. To continue investigating profitability, this company’s Return on Assets is posted at -0.2, Equity is -1.27 and Total Capital is -0.21. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 3.64.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.8281 points at the first support level, and at 0.8028 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.8707, and for the 2nd resistance point, it is at 0.8880.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Gossamer Bio Inc [NASDAQ:GOSS] is 6.74. As well, the Quick Ratio is 6.74, while the Cash Ratio is 0.56. Considering the valuation of this stock, the price to sales ratio is 1.84, the price to book ratio is 3.57.
Transactions by insiders
Recent insider trading involved Aranda Richard, Chief Medical Officer, that happened on Jun 24 ’24 when 1908.0 shares were sold. President & CEO, Hasnain Faheem completed a deal on Jun 21 ’24 to buy 0.37 million shares. Meanwhile, COO/CFO Giraudo Bryan bought 100000.0 shares on Jun 18 ’24.
